search icon

Is Hope for Alzheimer’s and Rare Childhood Disease to Restore Lost Brain Molecule?

Children born with the rare, genetic disease—RCDP—usually die within a few years due to loss of a vital brain molecule, plasmalogen, also found low in those with Alzheimer’s disease. Could restoring plasmalogens revive health for both conditions?

Watch our exclusive episode, only on NTD.

In 2007, Dr. Dayan Goodenowe discovered a single molecule much lower than normal in the blood of people with Alzheimer’s Disease. Using his own technology he identified that molecule as plasmalogen – a key brain molecule made in sufficient supply in the cells of a healthy, functioning body. Was loss of plasmalogen causing Alzheimer’s disease? What would happen if plasmalogen could be restored? The challenge was set.

Dr. Goodenowe has since invented a novel plasmalogen supplement being trialed by Alzhimer’s sufferers across America. But on the opposite end of the life spectrum, two children with a rare (1 in every 100,000 births) disease – RCDP* – display the most compelling results of this treatment.

How has life changed for six-year-old Thatcher and three-year-old Nova since having this lost, vital nutrient, restored? What signs are there that restoring plasmalogens could benefit Alzheimer’s sufferers?

*RCDP – rhizomelic chondrodysplasia punctata

 

Up next:

Remarkable signs of recovery from Alzheimer’s and other dementias in:

KEY TO CURE–Dementia Awakening ​​https://ept.ms/DementiaAwakening_VS3

KEY TO CURE–Alzheimer’s Antidote https://ept.ms/AlzheimersAntidote_VS

Get notice of new🔅Vital Signs videos:

Instagram: https://www.instagram.com/vitalsignsbrendon

X: https://twitter.com/seevitalsigns

Brendon𑛀IG https://www.instagram.com/brendonfallon.seen

You can find out more about Dr. Dayan Goodenowe’s research and treatments at: www.drgoodenowe.com and www.prodrome.com

—————————————————————————————————————————————–

Related research by Dr Goodenowe:

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer’s disease and dementia

https://www.jlr.org/article/S0022-2275(20)42448-4/fulltext

Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in

a Cross-Sectional Study

https://www.mdpi.com/2076-3425/9/4/92

Plasmalogen deficiency and neuropathology in Alzheimer’s disease: Causation or coincidence?

https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1016/j.trci.2019.08.003

Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species

https://www.frontiersin.org/articles/10.3389/fcell.2022.866156/full

Targeted Plasmalogen Supplementation: Effects on Blood Plasmalogens, Oxidative Stress Biomarkers, Cognition, and Mobility in Cognitively Impaired Persons

https://www.frontiersin.org/articles/10.3389/fcell.2022.864842/full

===================================================================================

Vital Signs’ host, guests, and contributors offer general information on improving health and wellness. This is not intended as diagnosis or medical advice. You should consult your medical doctor or holistic doctor before enacting any suggested strategies for health and wellness improvement, including those in relation to preventing or treating specific diseases featured on this program.

Views expressed in this video are opinions of the host and guests, and do not necessarily reflect the views of The Epoch Times.

Read More
Related Videos